Neuronetics (STIM) EBIT Margin (2017 - 2026)
Neuronetics' (STIM) quarterly EBIT Margin came in at 26.11% in Q1 2026, up 834.0% year-on-year from 2.8% in Q1 2025, and down 116.28% on a QoQ basis from 12.07% in Q4 2025.
Neuronetics (STIM) EBIT Margin (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of EBIT Margin data on file, last reported at 26.11% in Q1 2026.
- On a quarterly basis, EBIT Margin rose 834.0% year-over-year to 26.11% in Q1 2026; TTM through Mar 2026 was 19.4%, a 2389.0% increase from a year earlier, with the FY2025 full-year figure at 21.08%, up 2508.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 26.11%, down from 12.07% in the prior quarter.
- Over the last five years, EBIT Margin for STIM reached as high as 12.07% in Q4 2025 and fell as low as 71.47% in Q1 2022.
- Historically, EBIT Margin has averaged 40.78% across 5 years, with a median of 41.73% in 2023.
- Across the five-year window, EBIT Margin tumbled 2921 bps in 2024 and jumped 3893 bps in 2025, its largest moves.
- Year by year, EBIT Margin stood at 42.46% in 2022, then jumped by 49 bps to 21.79% in 2023, then sank by 134 bps to 51.0% in 2024, then jumped by 76 bps to 12.07% in 2025, then plunged by 116 bps to 26.11% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 26.11% in Q1 2026, 12.07% in Q4 2025, and 19.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | -26.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.11% |
| Dec 31, 2025 | -12.07% |
| Sep 30, 2025 | -19.63% |
| Jun 30, 2025 | -21.15% |
| Mar 31, 2025 | -34.45% |
| Dec 31, 2024 | -51.00% |
| Sep 30, 2024 | -41.71% |
| Jun 30, 2024 | -51.71% |
| Mar 31, 2024 | -39.38% |
| Dec 31, 2023 | -21.79% |
| Sep 30, 2023 | -49.60% |
| Jun 30, 2023 | -41.73% |
| Mar 31, 2023 | -63.75% |
| Dec 31, 2022 | -42.46% |
| Sep 30, 2022 | -45.18% |
| Jun 30, 2022 | -59.99% |
| Mar 31, 2022 | -71.47% |
| Dec 31, 2021 | -45.99% |
| Sep 30, 2021 | -52.05% |
| Jun 30, 2021 | -46.22% |